Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | USP2 | O75604 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | MLNR | O43193 | 1/20 | 0.60 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.60 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.60 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.60 |
| ▸ | PDE4A | P27815 | 1/20 | 0.60 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Floctafenine SCHEMBL29359218 | 1.00 | MAPK1 (0.60) | MAPK1HSD17B10CYP3A4USP2KDM4E | |
| Floctafenine SCHEMBL11774745 | 0.99 | MAPK1 (0.59) | MAPK1HSD17B10CYP3A4USP2KDM4E | |
| Floctafenine SCHEMBL28086336 | 0.90 | CYP3A4 (0.79) | MAPK1HSD17B10CYP3A4USP2KDM4E | |
| SCHEMBL11472410 | 0.89 | MAPK1 (0.50) | MAPK1HSD17B10CYP3A4USP2KDM4E | |
| SCHEMBL11063277 | 0.89 | MAPK1 (0.47) | MAPK1HSD17B10CYP3A4USP2KDM4E | |
| Floctafenine SCHEMBL6422149 | 0.86 | CYP3A4 (0.49) | MAPK1HSD17B10CYP3A4USP2KDM4E | |
| Floctafenine SCHEMBL10887375 | 0.85 | PTGS2 (0.46) | MAPK1HSD17B10CYP3A4USP2KDM4E | |
| Floctafenine SCHEMBL27701442 | 0.85 | CYP3A4 (0.47) | MAPK1HSD17B10CYP3A4USP2KDM4E | |
| SCHEMBL11796595 | 0.84 | GSK3A (0.50) | KDM4ECDC25BCDC25ACDC25CGSK3A | |
| Floctafenine SCHEMBL22635721 | 0.83 | HSD17B10 (0.46) | MAPK1HSD17B10CYP3A4USP2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5524 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ACERAGEN INC (US) | 2026-01-01 | — | — | US | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| WO-2025035205-A1 | PHARMACEUTICAL COMBINATIONS COMPRISING A SUBSTITUTED THIOPHENE FUSED CYCLOHEXANONE DERIVATIVE AND A CYCLOOXYGENASE (COX) INHIBITOR, AND THEIR USE FOR THE TREATMENT OF PAIN | NEURASIC THERAPEUTICS INC. (CA) | 2025-02-20 | — | — | WO | claimed |
| US-12226549-B2 | Synergistically cooperative compositions useful for soft tissue augmentation, drug delivery and related fields | ALTERGON S.A. (CH) | 2025-02-18 | — | — | US | claimed |
| US-20240165020-A1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-05-23 | — | — | US | claimed |
| EP-4360653-A2 | LIQUISOFT CAPSULES | Patheon Softgels Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| US-11872307-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2024-01-16 | — | — | US | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0963200-A2 | METHODS AND COMPOSITIONS FOR INHIBITION OF ANGIOGENESIS | The Children's Medical Center Corporation (US) | 1999-12-15 | — | — | EP | claimed |
| CN-1215589-A | Intra-articular preparation for treatment of arthropathy | SSP CO LTD (JP) | 1999-05-05 | — | — | CN | claimed |
| EP-0650361-B1 | COMPOSITIONS FOR THE TREATMENT OF ARTHRITIS CONTAINING PHOSPHONATES AND NSAIDS | PROCTER & GAMBLE PHARMA (US) | 1999-04-28 | — | — | EP | claimed |
| EP-0911025-A1 | Intra-articular preparation for the treatment of arthropathy | SSP Co., Ltd. (JP) | 1999-04-28 | — | — | EP | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| WO-1998019649-A2 | METHODS AND COMPOSITIONS FOR INHIBITION OF ANGIOGENESIS | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1998-05-14 | — | — | WO | claimed |
| EP-0725631-A1 | NOVEL METHOD FOR PREPARING DRY PHARMACEUTICALS CAPABLE OF VIRTUALLY INSTANTANEOUS DISINTEGRATION, AND RESULTING PHARMACEUTICALS | Vacher, Dominique (FR) | 1996-08-14 | — | — | EP | claimed |
| WO-1996002237-A1 | NOVEL METHOD FOR PREPARING DRY PHARMACEUTICALS CAPABLE OF VIRTUALLY INSTANTANEOUS DISINTEGRATION, AND RESULTING PHARMACEUTICALS | VACHER DOMINIQUE (FR) | 1996-02-01 | — | — | WO | claimed |
| US-3988459-A | 4-(O-(2',3'-DIHYDROXYPROPYLOXYCARBONYL)PHENYL)AMINO-8 -TRIFLUOROMETHYLQUINOLINE | ROUSSEL-UCLAF (FR) | 1976-10-26 | — | — | US | claimed |